Initial public offering (IPO) plans keep rolling in for Hong Kong’s revitalised capital market, with China’s largest pharmaceutical company launching another billion-dollar deal on Thursday.

Jiangsu Hengrui Pharmaceuticals Co. has started taking investor orders for a Hong Kong listing that could raise as much as ...

From micro-investment apps to startup accelerators and early-stage VC funds, this year’s Finance & Venture Capital listees ...

The U.S. and China have cut the tariffs levied on each other in April, with the U.S. cutting the 145% tax Trump imposed last ...

Asia-Pacific markets were set to fall Thursday, after mostly gaining in the previous session on easing U.S.-China trade ...

Tubs of protein-packed creamy cottage cheese have been flying off shelves. When did this unfashionable 'diet food' become so ...

Hong Kong’s investment banking job market is showing signs of a recovery, with the number of licensed professionals in the ...

Peter Coker Jr. received a 40 month sentence while his 82-year-old father Peter Coker Sr. was sentenced to six months, ...

China-based Jiangsu Hengrui Pharmaceuticals is seeking to raise up to HK$9.89 billion ($1.27 billion) in a Hong Kong initial public offering, according to a regulatory filing made on Thursday.

From blockchain-backed verifications to EVs and edtech platforms, entrepreneurs on the Consumer & Enterprise Technology list ...

Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions ...

Trump’s tariffs and trade deals continue to affect global markets. Follow along for live updates on the Dow, S&P 500 and Nasdaq.